Through bioinformatics analysis, our study found the relationship between AKR1C3 and sorafenib resistance and further proved that AKR1C3 downregulation can significantly increase the sensitivity of liver cancer cells to sorafenib. The gene discussed is AKR1C3; the disease is liver cancer.